Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)
Starting soon
Conditions studied: Lung Cancer
In brief
A prospective, longitudinal, single-arm interventional study of lung cancer screening.
Key facts
- Study ID
- NCT07279948
- Run by
- AstraZeneca
- People needed
- 477
- Starts
- 2026-08-31
- Expected to finish
- 2027-01-31
- Last updated by the study team
- 2026-08-03
Who can join
Age: 50 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- In order, to be eligible for the study, patients must fulfill all the following inclusion criteria:
- Age between ≥50 and ≤80 years.
- Be a current smoker or have quit 15 years ago or less.
- Have participated or are currently participating in smoking cessation program.
- Lifetime smoking exposure equal to or greater than 20 pack-year.
- Provided signed informed consent (ICF)
You may not qualify if…
- In order, to be exclude for the study, patients must at least one of the following exclusion criteria:
- Contraindications to the screening examination: (claustrophobic or weighing more than 130 kgs).
- Inability to climb 3 stair steps non-stop (36 steps).
- Disabling dyspnea
- Symptomatic (with signs and symptoms suspicious of breast cancer lung, namely):
- pleuritic chest pain
- rapidly progressive dyspnea of recent onset
- hemoptysis
- unexplained hoarseness, lasting more than 1 month.
- bone pain
- supraclavicular lymphadenopathy or cervical lymphadenopathy persistent
- unexplained weight loss of 5% or more of weight in less than 6 months
- Previous history of malignant neoplasm (excluding non-melanoma skin cancer) diagnosed less than 10 years before the date of the interview;
- Patients with diagnostic of severe psychiatric disease
- Immunosuppressed by illness or drugs.
- Subjected to anterior lung resection even when determined due to an etiology other than malignant neoplasia.
- Person with a serious terminal illness that contraindicates curative lung surgery.
Where it is running
- Research Site — Rio de Janeiro, Brazil
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.